Clinical Trials Logo

Clinical Trial Summary

This study is designed to test: 1. in patients with negative positron-emission tomography (PET) after 2 cycles of BEACOPPesc chemotherapy: whether the number of cycles can be reduced without compromising progression free survival (PFS) (2 further cycles vs. 6 further cycles) 2. for patients with positive PET after 2 cycles: whether intensifying BEACOPPesc chemotherapy by adding Rituximab improves PFS.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT00515554
Study type Interventional
Source University of Cologne
Contact
Status Completed
Phase Phase 3
Start date May 2008
Completion date July 2020

See also
  Status Clinical Trial Phase
Terminated NCT00383097 - Lmp1 and Lmp2 Specific CTLs Following Cd45 Antibody for Relapsed Ebv-Positive Hodgkin's Or Non-Hodgkin's Lymphoma Phase 1
Completed NCT01517581 - Brown Fat Activity and White Fat Accumulation N/A
Terminated NCT01326728 - Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic Stem Cell Transplantation
Completed NCT00837200 - Oncaspar/Doxil/Decadron in Patients With Refractory Lymphoid Malignancies Phase 2
Terminated NCT02603419 - Avelumab In Patients With Previously Treated Advanced Stage Classical Hodgkin's Lymphoma (JAVELIN HODGKINS) Phase 1
Active, not recruiting NCT02099266 - Use of Hyperbaric Oxygen Therapy to Improve Umbilical Cord Blood Stem Cell Homing and Subsequent Engraftment N/A
Completed NCT02057445 - 3rd Party LMP1/2-Specific Cytotoxic T Lymphocytes for EBV-Associated Lymphoma Phase 1
Terminated NCT01636388 - Allogeneic Stem Cell Transplantation With Adoptive Immunotherapy in Epstein-Barr Virus Positive Recurrent/Refractory Hodgkins Lymphoma Phase 2
Terminated NCT01300611 - TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation Phase 1
Completed NCT01014507 - Protection of Ovarian Function in Female Patients With Hodgkin Lymphoma Phase 2
Enrolling by invitation NCT00923442 - Biology Studies of Hematologic Cancers
Terminated NCT00973804 - Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukemias, Lymphomas, and Pre-Malignant Blood Disorders Phase 1
Completed NCT00739141 - Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies. Phase 2
Recruiting NCT05134740 - (TAA)-Specific Cytotoxic T-Lymphocytes to Pediatric Patients With Lymphomas (pediTACTAL). Phase 1
Completed NCT01572662 - Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning Phase 2